Jonak v. Novartis Pharmaceuticals Corporation
| Susan Jonak |
| Novartis Pharmaceuticals Corporation |
| 6:2023cv00873 |
| May 11, 2023 |
| US District Court for the Middle District of Florida |
| David A Baker |
| Roy B Dalton |
| Tort Product Liability |
| 28 U.S.C. § 1332 Diversity-Product Liability |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 30 NOTICE TO COUNSEL: Parties who have been permitted by the Court to appear telephonically at the August 30, 2023 Status Conference shall join the conference by dialing 1-888-684-8852 ten minutes before the hearing is scheduled to begin. Access Code: 5851307. Security Code: 083023. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL) |
| Filing 29 NOTICE of hearing: Status Conference set for 8/30/2023 at 10:00 AM in Orlando Courtroom 4 A before Judge Roy B. Dalton, Jr. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL) |
| Filing 28 PLAINTIFF'S Exhibit List (Evidentiary Hearing). Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 27 DEFENDANT'S Exhibit List (Evidentiary Hearing). Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 26 Minute Entry for In Person Proceedings held before Judge Roy B. Dalton, Jr.: Evidentiary Hearing (DAY TWO) held on 6/6/2023. Court Reporter: Amie First. Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 25 Minute Entry for In Person Proceedings held before Judge Roy B. Dalton, Jr.: Evidentiary Hearing (DAY ONE) held on 6/5/2023. Court Reporter: Amie First. Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 24 PROOF of service by Susan Jonak (Wichmann, Lawana) |
| Filing 23 Remark: Doc. #21 has been reviewed. Signed by Judge Roy B. Dalton, Jr. on 5/18/2023. (EP) |
Filing 22
PRETRIAL ORDER NO. 10: The parties in tagalong cases transferred into this MDL after dispositive motions were filed are DIRECTED to file notices indicating whether they adopt the MDL-wide summary judgment briefing (Docs. 238, 257, 268) by Wednesday, May 31, 2023. By Wednesday, May 31, 2023, Plaintiffs are ORDERED TO SHOW CAUSE by written response why the Bayack case should not be dismissed. The proposed schedule for post-remand case-specific discovery in the Middle District of Florida member cases is now due Wednesday, May 31, 2023. The Motion to Modify the Evidentiary Hearing Schedule (Doc. 274) is DENIED. Signed by Judge Roy B. Dalton, Jr. on 5/17/2023. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL)
|
| Filing 21 CORPORATE Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis AG, a Swiss company, whose shares are publicly traded on the SIX Swiss Exchange, and whose American Depository Shares are publicly traded on the New York Stock Exchange, Corporate Parent Novartis Holding, AG, a Swiss company for Novartis Pharmaceuticals Corporation. (Johnston, Robert) Modified on 5/18/2023 to edit docket text (SRD). |
| Filing 20 ANSWER and affirmative defenses to #1 Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Johnston, Robert) |
| Filing 19 TRANSFER IN from the Nebraska. Case assigned to District Judge Roy B. Dalton, Jr. and Magistrate Judge David A. Baker. New Case Number: 6:23-cv-873-RBD-DAB. (RPB) |
| Filing 18 Case transferred in from District of Nebraska; Case Number 8:23-cv-00089. File received electronically |
| Filing 17 CERTIFIED COPY OF CONDITIONAL TRANSFER ORDER. Case is transferred to USDC-USDC-Middle District of Florida, Docket No. 3006., Civil Case Terminated. (Attachments: #1 E-mail from MDL Court)(MKR) [Transferred from ned on 5/11/2023.] |
| Case transferred to District of USDC-Middle District of Florida- MDL 3006. Original electronic file sent. (MKR) [Transferred from ned on 5/11/2023.] |
| MULTIDISTRICT LITIGATION Member Case. Create association to 6:21-md-03006-RBD-DAB, lead case for MDL. (RPB) |
| Filing 16 COPY OF CONDITIONAL TRANSFER ORDER from the Multidistrict Litigation Panel. Clerk to wait for certified copy of order to transfer the file to USDC-USDC-Middle District of Florida, Docket No. 3006. (Attachments: #1 MDL Transmittal Email) (MKR) [Transferred from ned on 5/11/2023.] |
| Filing 15 Mail Returned as Undeliverable addressed to Richard Elias regarding Order to Show Cause - Attorney Deadline, #6. NOT REMAILED- COUNSEL HAS REGISTERED AND UPDATED THEIR ADDRESS. (MKR) [Transferred from ned on 5/11/2023.] |
| Filing 14 TEXT ORDER granting Motion for Admission Pro Hac Vice #12 for attorney James G. Onder. Ordered by Deputy Clerk. (LKO) [Transferred from ned on 5/11/2023.] |
| Filing 13 TEXT ORDER granting Motion for Admission Pro Hac Vice #11 for attorney Lawana S. Wichmann. Ordered by Deputy Clerk. (LKO) [Transferred from ned on 5/11/2023.] |
| Filing 12 MOTION for Admission Pro Hac Vice Filing fee $ 100, receipt number ANEDC-4851661 by Attorney James G. Onder on behalf of Plaintiff Susan Jonak.(Onder, James) [Transferred from ned on 5/11/2023.] |
| Filing 11 MOTION for Admission Pro Hac Vice Filing fee $ 100, receipt number ANEDC-4851638 by Attorney Lawana S. Wichmann on behalf of Plaintiff Susan Jonak.(Wichmann, Lawana) [Transferred from ned on 5/11/2023.] |
| Filing 10 TEXT ORDER granting Motion for Admission Pro Hac Vice #9 for attorney Richard M. Elias. Ordered by Deputy Clerk. (LKO) [Transferred from ned on 5/11/2023.] |
| Filing 9 MOTION for Admission Pro Hac Vice Filing fee $ 100, receipt number ANEDC-4851532 by Attorney Richard M. Elias on behalf of Plaintiff Susan Jonak.(Elias, Richard) [Transferred from ned on 5/11/2023.] |
| Filing 8 Summons Issued as to defendant Novartis Pharmaceuticals Corporation. YOU MUST PRINT YOUR ISSUED SUMMONS, WHICH ARE ATTACHED TO THIS DOCUMENT. PAPER COPIES WILL NOT BE MAILED. (JES) [Transferred from ned on 5/11/2023.] |
| Filing 7 Summons Requested as to Novartis Pharmaceuticals Corporation regarding Complaint#1. (Welsh, Christopher) [Transferred from ned on 5/11/2023.] |
|
Filing 6
ORDER TO SHOW CAUSE- On or before April 27, 2023, attorneys Richard Elias, James G. Onder, and Lawana S. Wichman must register for the System or show cause by written affidavit why compliance is not possible as required under the rules of the court. Show Cause Deadline set for 4/27/2023. Ordered by Magistrate Judge Cheryl R. Zwart. (Copy mailed to pro se party) (MKR) [Transferred from ned on 5/11/2023.]
|
| Filing 5 ATTORNEY LETTER by Clerk that Attorney Lawana S. Wichmann has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (JES) [Transferred from ned on 5/11/2023.] |
| Filing 4 ATTORNEY LETTER by Clerk that Attorney James G. Onder has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (JES) [Transferred from ned on 5/11/2023.] |
| Filing 3 ATTORNEY LETTER by Clerk that Attorney Richard Elias has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (JES) [Transferred from ned on 5/11/2023.] |
| Filing 2 TEXT NOTICE OF JUDGES ASSIGNED: Senior Judge Joseph F. Bataillon and Magistrate Judge Cheryl R. Zwart assigned. In accordance with 28 U.S.C. 636(c)(2), the parties are notified that, if all parties consent, a magistrate judge may conduct a civil action or proceeding, including a jury or nonjury trial, subject to the courts rules and policies governing the assignment of judges in civil cases. See Fed. R. Civ. P. 73; NEGenR 1.4. (JES) [Transferred from ned on 5/11/2023.] |
| Filing 1 COMPLAINT with jury demand against Novartis Pharmaceuticals Corporation ( Filing fee $ 402, receipt number ANEDC-4820038), by Attorney Christopher P. Welsh on behalf of Susan Jonak(Welsh, Christopher) [Transferred from ned on 5/11/2023.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Jonak v. Novartis Pharmaceuticals Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Susan Jonak | |
| Represented By: | Christopher P. Welsh |
| Represented By: | James G. Onder |
| Represented By: | Lawana Sue Wichmann |
| Represented By: | Richard M. Elias |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Novartis Pharmaceuticals Corporation | |
| Represented By: | Robert E. Johnston |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
